Avanir falls on allegations of off-label marketing

Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) fell $0.74 (13%) to $4.79 on Wednesday after an anonymous post on investor site Seeking Alpha alleged Avanir is engaged in off-label marketing of its sole mar...